Will Teva take over the commercialization of Zolpimist in Australia now Suda has the MAA.
They did have an option for Australia when the deal was signed back in 2017.
Question is will they pay up front payment and if so what price will it be and what royalties will they pay.
As for Stride SUD 001 last update was the development was nearing completion but yet to enter human trials
Suda also has 2 Zolpimist deals with Mitsubishi, will getting the MAA approval assist them in submitting MAAs for their territories
Finally shareholders may have somethings to look forward to.
The dawn of a new SUDA, page-37
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.5¢ | 13.5¢ | $174.0K | 1.245M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61995 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 183155 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |